NMS·Healthcare·$456M·#129 / 520 in Healthcare
NRC National Research Corporation
61SOLID
CATEGORY BREAKDOWN
GROWTH0
QUALITY68
STABILITY67
VALUATION87
GOVERNANCE100
METRIC BREAKDOWN
Revenue Growth (YoY)
Year-over-year revenue growth rate
-4.0%
0
> 50% strong
Gross Margin
Revenue retained after direct costs
61.9%
88
> 50% strong
Cash Runway
Months of cash at current burn rate
999 months
100
> 24 months ideal
Debt / Equity
Total debt relative to shareholder equity
564.9%
0
< 25% strong
Price / Sales
Market cap relative to trailing revenue
3.3x
87
< 3x strong
Rule of 40
Growth rate plus operating margin
12
39
> 40 excellent
Insider Ownership
Percentage of shares held by insiders
49.0%
100
> 20% strong
Share Dilution (12M)
Share count increase over last 12 months
-29.1%
100
< 5% ideal
SCORE HISTORY
RELATED STOCKS
COMPARE NRC WITH…
OR QUICK-COMPARE SECTOR PEERS
RELATED RESEARCH
3 Best Small-Cap SMR & Nuclear Tech Stocks — Q2 2026Apr 24, 2026SCORE ALERT
Get notified when NRC's score changes by 5+ points.
DATA INFO
Last updated: Jun 2, 2026
Sources: SEC EDGAR, Financial Modeling Prep, Yahoo Finance. Not financial advice.